Repligen Reports Second Quarter 2015 Financial Results
Product Sales Increase 38% to a Record $21.5 Million
Conference Call and Webcast Today at 8:30 a.m. ET WALTHAM, Mass., Aug. 06, 2015 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the second quarter and six-month (year-to-date) periods ended June 30, 2015. Below are the Company’s performance highlights, followed by updated financial guidance for the year 2015 and access information for today’s webcast and conference call. Second Quarter and Year-to-Date Financial Highlights Product revenue for the second quarter of 2015 was $21.5 million compared to $15.6 million for the second quarter of 2014, an increase of 38% which includes a negative impact of 11% from foreign currency translation. For the six-month period, product revenue was $42.3 million compared to $29.9 million for the same period in 2014, an increase of 41%. Total revenue
